The decision to stay on semaglutide long-term depends on three main factors: how much weight was lost, baseline metabolic rate, and success with diet and exercise adherence
Tirzepatide , a GLP-1/GIP receptor dual agonist developed by Eli Lilly, and survodutide , a Glucagon and GLP-1 receptor dual agonist developed jointly by Boehringer Ingelheim and Zealand Pharma, both obtained preliminary positive results in Phase 2 clinical trials for treating NASH in February of 2024
10.37557/gjphm.v7i1.336 Glob J Public Health Med
For optimal absorption, L-Glutamine by itself / in free form is the way to go
Methionine is instrumental in breaking down fats in the liver, inositol functions as a sugar that regulates insulin and mood, and choline is crucial for liver health and fat metabolism
It works for both men and women, comes with a 100-day money-back guarantee, and has thousands of verified positive reviews